These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 20973621)
1. Correction of hyperbilirubinemia in gunn rats using clinically relevant low doses of helper-dependent adenoviral vectors. Dimmock D; Brunetti-Pierri N; Palmer DJ; Beaudet AL; Ng P Hum Gene Ther; 2011 Apr; 22(4):483-8. PubMed ID: 20973621 [TBL] [Abstract][Full Text] [Related]
2. Improved efficacy and reduced toxicity by ultrasound-guided intrahepatic injections of helper-dependent adenoviral vector in Gunn rats. Pastore N; Nusco E; Piccolo P; Castaldo S; Vaníkova J; Vetrini F; Palmer DJ; Vitek L; Ng P; Brunetti-Pierri N Hum Gene Ther Methods; 2013 Oct; 24(5):321-7. PubMed ID: 23947957 [TBL] [Abstract][Full Text] [Related]
3. Correction of hyperbilirubinemia in gunn rats by surgical delivery of low doses of helper-dependent adenoviral vectors. Schmitt F; Pastore N; Abarrategui-Pontes C; Flageul M; Myara A; Laplanche S; Labrune P; Podevin G; Nguyen TH; Brunetti-Pierri N Hum Gene Ther Methods; 2014 Jun; 25(3):181-6. PubMed ID: 24593043 [TBL] [Abstract][Full Text] [Related]
4. Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Toietta G; Mane VP; Norona WS; Finegold MJ; Ng P; McDonagh AF; Beaudet AL; Lee B Proc Natl Acad Sci U S A; 2005 Mar; 102(11):3930-5. PubMed ID: 15753292 [TBL] [Abstract][Full Text] [Related]
5. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase. Askari FK; Hitomi Y; Mao M; Wilson JM Gene Ther; 1996 May; 3(5):381-8. PubMed ID: 9156798 [TBL] [Abstract][Full Text] [Related]
6. Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats. Jia Z; Dankó I Hum Gene Ther; 2005 Aug; 16(8):985-95. PubMed ID: 16076256 [TBL] [Abstract][Full Text] [Related]
7. Sustained reduction of hyperbilirubinemia in Gunn rats after adeno-associated virus-mediated gene transfer of bilirubin UDP-glucuronosyltransferase isozyme 1A1 to skeletal muscle. Pastore N; Nusco E; Vaníkova J; Sepe RM; Vetrini F; McDonagh A; Auricchio A; Vitek L; Brunetti-Pierri N Hum Gene Ther; 2012 Oct; 23(10):1082-9. PubMed ID: 22765254 [TBL] [Abstract][Full Text] [Related]
9. In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV. Montenegro-Miranda PS; Pichard V; Aubert D; Ten Bloemendaal L; Duijst S; de Waart DR; Ferry N; Bosma PJ Gene Ther; 2014 Feb; 21(2):168-74. PubMed ID: 24285217 [TBL] [Abstract][Full Text] [Related]
10. Towards liver-directed gene therapy for Crigler-Najjar syndrome. Miranda PS; Bosma PJ Curr Gene Ther; 2009 Apr; 9(2):72-82. PubMed ID: 19355865 [TBL] [Abstract][Full Text] [Related]
11. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome. Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428 [TBL] [Abstract][Full Text] [Related]
12. Transient increase in intrahepatic pressure mediates successful treatment of the Gunn rat with reduced doses of lentiviral vector. Schmitt F; Flageul M; Dariel A; Pichard V; Pontes CA; Boni S; Podevin G; Myara A; Ferry N; Nguyen TH Hum Gene Ther; 2010 Oct; 21(10):1349-56. PubMed ID: 20486774 [TBL] [Abstract][Full Text] [Related]
13. Nonviral gene transfer into liver and muscle for treatment of hyperbilirubinemia in the gunn rat. Dankó I; Jia Z; Zhang G Hum Gene Ther; 2004 Dec; 15(12):1279-86. PubMed ID: 15684703 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats. Nguyen TH; Bellodi-Privato M; Aubert D; Pichard V; Myara A; Trono D; Ferry N Mol Ther; 2005 Nov; 12(5):852-9. PubMed ID: 16140582 [TBL] [Abstract][Full Text] [Related]
15. Gunn Rats as a Surrogate Model for Evaluation of Hepatocyte Transplantation-Based Therapies of Crigler-Najjar Syndrome Type 1. Polgar Z; Li Y; Li Wang X; Guha C; Roy-Chowdhury N; Roy-Chowdhury J Methods Mol Biol; 2017; 1506():131-147. PubMed ID: 27830550 [TBL] [Abstract][Full Text] [Related]
16. Critical assessment of lifelong phenotype correction in hyperbilirubinemic Gunn rats after retroviral mediated gene transfer. Nguyen TH; Aubert D; Bellodi-Privato M; Flageul M; Pichard V; Jaidane-Abdelghani Z; Myara A; Ferry N Gene Ther; 2007 Sep; 14(17):1270-7. PubMed ID: 17611583 [TBL] [Abstract][Full Text] [Related]
17. AAV8 Gene Therapy Rescues the Newborn Phenotype of a Mouse Model of Crigler-Najjar. Greig JA; Nordin JML; Draper C; Bell P; Wilson JM Hum Gene Ther; 2018 Jul; 29(7):763-770. PubMed ID: 29448836 [TBL] [Abstract][Full Text] [Related]
18. Gunn rat: a model for inherited deficiency of bilirubin glucuronidation. Chowdhury JR; Kondapalli R; Chowdhury NR Adv Vet Sci Comp Med; 1993; 37():149-73. PubMed ID: 8273513 [TBL] [Abstract][Full Text] [Related]
19. Correction of congenital indirect hyperbilirubinemia by small intestinal transplantation. Medley MM; Hooker RL; Rabinowitz S; Holton R; Jaffe BM Am J Surg; 1995 Jan; 169(1):20-7. PubMed ID: 7817994 [TBL] [Abstract][Full Text] [Related]
20. Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1. Li Q; Murphree SS; Willer SS; Bolli R; French BA Hum Gene Ther; 1998 Mar; 9(4):497-505. PubMed ID: 9525311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]